EUVIMEDEUVIMED entdecken
CrossrefInfokarte

2025 International Consensus Meeting on Musculoskeletal Infection: Summary From the Biofilm Workgroup on Biofilm Formation, Persistence, and Host‐Environment Interactions

Gowrishankar Muthukrishnan, Débora C. Coraça‐Huber, Gerald J. Atkins, Ahmad Abbaszadeh, Armita A. Abedi, Ezzuddin Abuhussein, Joshua S. Bingham, Kyle H. Cichos, Tom Coenye, Lorenzo Drago, John Hamilton, Noreen J. Hickok, Ferdinando Iannotti, Jessica Amber Jennings, Louise Kruse Jensen, Bingyun Li, Mojieb Manzary, T. Fintan Moriarty, Katya McDonald, Kohei Nishitani, Nicholas Norton, Ebru Oral, Javad M. Parvizi, Dina Raafat, Kordo Saeed, Imre Sallai, Edward M. Schwarz, Claudia Siverino, Amita Sekar, Jermiah Tate, Margarita Trobos, Andie Tubbs

Journal of Orthopaedic Research · 2026-01 · 44 (1)

DOI: 10.1002/jor.70130 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Musculoskeletal infection (MSKI) remains a major problem after trauma and elective orthopedic surgery. Chronic MSKI is related to the formation of biofilm, which impairs diagnosis and effective treatments. Therefore, to understand and communicate global standards and best practices, the 2025 International Consensus Meeting (ICM) on MSKI created a Biofilm Section to address crucial aspects of biofilm biology pertaining to its mechanisms of drug resistance and immune evasion, and potential approaches to overcome them. This featured a 2‐year process, with final voting and discussion on May 8–10, 2025, in Istanbul, Turkey. This Consensus Article is the effort of the Biofilm Basic Mechanisms Workgroup, which interpreted the results on ICM questions related to (1) the infectious microenvironment; (2) appropriate inocula in preclinical research; (3) biofilm behavior in infected tissues; and (4) synergy within biofilms and with other comorbidities. Collectively, we find that this field has the necessary research tools to discover the pathophysiology of orthopedic implant‐associated biofilm development and maturation, perform clinically relevant studies in animal models, and elucidate mechanisms that allow opportunistic infections in compromised tissues and patients with other health issues.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →